Acrolein contributes to human colorectal tumorigenesis through the activation of RAS-MAPK pathway
Abstract Colorectal cancer (CRC) is one of the most well-known malignancies with high prevalence and poor 5-year survival. Previous studies have demonstrated that a high-fat diet (HFD) is capable of increasing the odds of developing CRC. Acrolein, an IARC group 2A carcinogen, can be formed from carb...
Guardado en:
Autores principales: | Hong-Chieh Tsai, Han-Hsing Tsou, Chun-Chi Lin, Shao-Chen Chen, Hsiao-Wei Cheng, Tsung-Yun Liu, Wei-Shone Chen, Jeng-Kai Jiang, Shung-Haur Yang, Shih-Ching Chang, Hao-Wei Teng, Hsiang-Tsai Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5177caa898a641d98b6a15973fb91965 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Author Correction: Acrolein contributes to human colorectal tumorigenesis through the activation of RAS-MAPK pathway
por: Hong-Chieh Tsai, et al.
Publicado: (2021) -
Neuroprotective effect of selumetinib on acrolein-induced neurotoxicity
por: Hui-Ju Huang, et al.
Publicado: (2021) -
Preference criteria for regorafenib in treating refractory metastatic colorectal cancer are the small tumor burden, slow growth and poor/scanty spread
por: Hung-Chih Hsu, et al.
Publicado: (2021) -
Aurora kinase A (AURKA) interaction with Wnt and Ras-MAPK signalling pathways in colorectal cancer
por: Annika Jacobsen, et al.
Publicado: (2018) -
Gut Microbial Glycerol Metabolism as an Endogenous Acrolein Source
por: Jianbo Zhang, et al.
Publicado: (2018)